Kyntra Bio, Inc. (KYNB) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Kyntra Bio, Inc. (KYNB) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry, with a market capitalization near $28.4M, listed on NASDAQ, employing roughly 225 people, carrying a beta of 1.04 to the broader market. Kyntra Bio, Inc. Led by Thane Wettig, public since 2014-11-14.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for KYNB as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →